| ARMATA PHARMACEUT. |
| USA |
| Gesundheit |
| US04216R1023 / A2PKLC |
| TG1N (Frankfurt) |
| FRA:TG1N, ETR:TG1N, TG1N:GR |
| - |
| https://www.armatapharma... |
|
Armata Pharmaceuticals Inc. is a biotechnology company dedicated to the development of innovative therapies to treat antibiotic-resistant infections. Operating in the healthcare sector, the company fo..
>Volltext.. |
| 271.74 Mio. EUR |
| 510.05 Mio. EUR |
| 4.25 Mio. EUR |
| -25.74 Mio. EUR |
| -150.66 Mio. EUR |
| -4.15 EUR |
| 249.68 Mio. EUR |
| 7.53 Mio. EUR |
| -22.33 Mio. EUR |
| 0.97 |
| -16.46% |
| -709.83% |
| - |
| - |
| - |
| - |
| ARMATA |
| 28.03.26 |
|